XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial Instruments and Fair Value | 3 Months Ended
--- | ---
Mar. 31, 2025
Financial Instruments and Fair Value [Abstract] |
FINANCIAL INSTRUMENTS AND FAIR VALUE | FINANCIAL INSTRUMENTS AND FAIR VALUE Short-Term and Long-Term Investments Our short-term and long-term investments comprised of available-for-sale investments and marketable equity securities. The following tables summarize our short-term and long-term investments (in millions):
| March 31, 2025
| Amortized Cost |  | Unrealized Gains |  | Unrealized Losses |  | Fair Value
U.S. government and agency securities | $ | 486.5 |  |  | $ | 0.2 |  |  | $ | — |  |  | $ | 486.7 |
Commercial paper | 432.8 |  |  | 0.1 |  |  | (0.1) |  |  | 432.8 |
Corporate debt securities | 158.2 |  |  | — |  |  | (0.1) |  |  | 158.1 |
Certificates of deposit and term deposits | 73.9 |  |  | — |  |  | — |  |  | 73.9 |
Total available-for-sale investments | 1,151.4 |  |  | 0.3 |  |  | (0.2) |  |  | 1,151.5 |
Marketable equity securities |  |  |  |  |  |  | 67.6 |
Total short-term and long-term investments | $ | 1,151.4 |  |  | $ | 0.3 |  |  | $ | (0.2) |  |  | $ | 1,219.1 |
| December 31, 2024
| Amortized Cost |  | Unrealized Gains |  | Unrealized Losses |  | Fair Value
U.S. government and agency securities | $ | 469.1 |  |  | $ | 0.4 |  |  | $ | — |  |  | $ | 469.5 |
Commercial paper | 428.7 |  |  | 0.2 |  |  | (0.2) |  |  | 428.7 |
Corporate debt securities | 166.4 |  |  | 0.1 |  |  | (0.1) |  |  | 166.4 |
Certificates of deposit and term deposits | 61.8 |  |  | — |  |  | — |  |  | 61.8 |
Total available-for-sale investments | 1,126.0 |  |  | 0.7 |  |  | (0.3) |  |  | 1,126.4 |
Marketable equity securities |  |  |  |  |  |  | 64.2 |
Total short-term and long-term investments | $ | 1,126.0 |  |  | $ | 0.7 |  |  | $ | (0.3) |  |  | $ | 1,190.6 |
The following tables show the gross unrealized losses and the related fair values of our available-for-sale investments that have been in a continuous unrealized loss position (in millions):
| March 31, 2025
| Less Than 12 Months |  | 12 Months or Greater |  | Total
| Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses
U.S. government and agency securities | $ | 119.7 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 119.7 |  |  | $ | — |
Commercial paper | 260.5 |  |  | (0.1) |  |  | — |  |  | — |  |  | 260.5 |  |  | (0.1) |
Corporate debt securities | 83.8 |  |  | (0.1) |  |  | — |  |  | — |  |  | 83.8 |  |  | (0.1) |
Certificates of deposit and term deposits | 9.5 |  |  | — |  |  | — |  |  | — |  |  | 9.5 |  |  | — |
Total available-for-sale investments | $ | 473.5 |  |  | $ | (0.2) |  |  | $ | — |  |  | $ | — |  |  | $ | 473.5 |  |  | $ | (0.2) |
| December 31, 2024
| Less Than 12 Months |  | 12 Months or Greater |  | Total
| Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses
U.S. government and agency securities | $ | 27.8 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 27.8 |  |  | $ | — |
Commercial paper | 149.4 |  |  | (0.2) |  |  | — |  |  | — |  |  | 149.4 |  |  | (0.2) |
Corporate debt securities | 63.5 |  |  | (0.1) |  |  | — |  |  | — |  |  | 63.5 |  |  | (0.1) |
Certificates of deposit and term deposits | 10.9 |  |  | — |  |  | — |  |  | — |  |  | 10.9 |  |  | — |
Total available-for-sale investments | $ | 251.6 |  |  | $ | (0.3) |  |  | $ | — |  |  | $ | — |  |  | $ | 251.6 |  |  | $ | (0.3) |
The contractual maturities of our available-for-sale investments were (in millions):
| March 31, 2025 |  | December 31, 2024
Due within one year | $ | 1,116.3 |  |  | $ | 1,126.4 |
Due within one to three years | 35.2 |  |  | — |
Total | $ | 1,151.5 |  |  | $ | 1,126.4 |
Available-for-sale investments are reported at fair value, with unrealized gains and losses and the related tax impact included as a separate component of stockholders’ equity and in comprehensive income. We do not intend to sell any of the securities in an unrealized loss position and it is not more likely than not that we would be required to sell these securities before recovery of their amortized cost basis, which may be at maturity. Realized gains and losses on available-for-sale investments were insignificant in the periods presented. Our marketable equity securities were $67.6 million and $64.2 million as of March 31, 2025 and December 31, 2024. The changes in fair value of our marketable equity securities are recorded in other income (expense)—net on the condensed consolidated statements of income. We recognized a $14.7 million loss and $0.3 million gain during the three months ended March 31, 2025 and 2024, respectively. Assets Measured at Fair Value on a Recurring Basis The following tables present the fair value of our financial assets measured at fair value on a recurring basis (in millions):
| March 31, 2025 |  | December 31, 2024
| Aggregate Fair Value |  | Quoted Prices in Active Markets For Identical Assets |  | Significant Other Observable Remaining Inputs |  | Significant Other Unobservable Remaining Inputs |  | Aggregate Fair Value |  | Quoted Prices in Active Markets For Identical Assets |  | Significant Other Observable Remaining Inputs |  | Significant Other Unobservable Remaining Inputs
|  |  | (Level 1) |  | (Level 2) |  | (Level 3) |  |  |  | (Level 1) |  | (Level 2) |  | (Level 3)
Cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds | $ | 260.3 |  |  | $ | 260.3 |  |  | $ | — |  |  | $ | — |  |  | $ | 296.1 |  |  | $ | 296.1 |  |  | $ | — |  |  | $ | — |
Commercial paper | 86.5 |  |  | — |  |  | 86.5 |  |  | — |  |  | 59.7 |  |  | — |  |  | 59.7 |  |  | — |
Total cash equivalents | 346.8 |  |  | 260.3 |  |  | 86.5 |  |  | — |  |  | 355.8 |  |  | 296.1 |  |  | 59.7 |  |  | — |
Short-term investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. government and agency securities | 451.5 |  |  | 446.5 |  |  | 5.0 |  |  | — |  |  | 469.5 |  |  | 464.5 |  |  | 5.0 |  |  | — |
Commercial paper | 432.8 |  |  | — |  |  | 432.8 |  |  | — |  |  | 428.7 |  |  | — |  |  | 428.7 |  |  | — |
Corporate debt securities | 158.1 |  |  | — |  |  | 158.1 |  |  | — |  |  | 166.4 |  |  | — |  |  | 166.4 |  |  | — |
Certificates of deposit and term deposits | 73.9 |  |  | — |  |  | 73.9 |  |  | — |  |  | 61.8 |  |  | — |  |  | 61.8 |  |  | — |
Marketable equity securities | 67.6 |  |  | 67.6 |  |  | — |  |  | — |  |  | 64.2 |  |  | 64.2 |  |  | — |  |  | — |
Total short-term investments | 1,183.9 |  |  | 514.1 |  |  | 669.8 |  |  | — |  |  | 1,190.6 |  |  | 528.7 |  |  | 661.9 |  |  | — |
Long-term investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. government and agency securities | 35.2 |  |  | 35.2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Total | $ | 1,565.9 |  |  | $ | 809.6 |  |  | $ | 756.3 |  |  | $ | — |  |  | $ | 1,546.4 |  |  | $ | 824.8 |  |  | $ | 721.6 |  |  | $ | — |
There were no transfers between Level 1 and Level 2 of the fair value hierarchy during the three months ended March 31, 2025 and year ended December 31, 2024.

X
- Definition Financial Instruments and Fair Value [Abstract] + References No definition available. + Details
Name: | ftnt_FinancialInstrumentsAndFairValueAbstract
Namespace Prefix: | ftnt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration